Beck-Pancer Devora, Aghaee Sara, Swint Alysia, Acker Julia, Deardorff Julianna, Kubo Ai
School of Public Health, University of California, Berkeley, CA, USA.
School of Medicine, University of California, San Francisco, CA, USA.
Clin Epidemiol. 2023 May 8;15:613-628. doi: 10.2147/CLEP.S380894. eCollection 2023.
Children of mothers with prenatal depression have elevated risk for depression later in life. Pregnant women are hesitant to use antidepressants due to fear of adverse fetal effects. To inform prevention, this study examined associations between maternal prenatal depression and antidepressant use, and adolescent depressive symptoms and suicidality.
Prospective data from 74,695 mother-adolescent dyads from the Kaiser Permanente Northern California integrated healthcare delivery system were used. Three prenatal exposure groups were examined: maternal depression and antidepressants (Med); depression and no antidepressants (No-Med); neither depression nor antidepressants (NDNM). Adolescent depressive symptoms (Patient Health Questionnaire-2 score ≥3) and suicidality were assessed for 12- to 18-year-olds. Associations were analyzed using mixed effects logistic regression, adjusted for confounders.
Maternal prenatal depression was associated with higher odds of adolescent depressive symptoms (Med odds ratio [OR]: 1.50, 95% confidence interval [CI]: 1.23-1.84; No-Med OR: 1.59, CI: 1.34-1.88) and suicidality (Med OR: 2.36, CI: 1.67-3.34; No-Med OR: 1.54, CI: 1.10-2.14) compared to no prenatal depression (NDNM). Adolescents exposed to prenatal depression and antidepressants were not at greater odds of depressive symptoms (Med OR: 0.95, CI: 0.74-1.21) compared to those not exposed to antidepressants (No-Med). However, they showed non-significant but greater odds of suicidality (Med OR: 1.54, CI: 0.99-2.39).
Our findings suggest that maternal prenatal depression is associated with adolescent depressive symptoms and suicidality, and that exposure to antidepressants in utero does not increase risk of depressive symptoms, specifically. While not statistically significant, the increased odds of suicidality among adolescents exposed to antidepressants suggest a possible association; however, further investigation is needed. After replication, the findings of this study may inform shared clinical decision-making when considering options regarding antidepressant use for the treatment of maternal prenatal depression.
母亲孕期抑郁的孩子日后患抑郁症的风险会升高。孕妇因担心对胎儿产生不良影响而不愿使用抗抑郁药。为指导预防工作,本研究调查了母亲孕期抑郁及抗抑郁药使用情况与青少年抑郁症状及自杀倾向之间的关联。
使用了来自北加利福尼亚凯撒医疗集团综合医疗服务系统的74,695对母婴的前瞻性数据。研究了三个孕期暴露组:母亲抑郁且使用抗抑郁药(用药组);抑郁但未使用抗抑郁药(未用药组);既无抑郁也未使用抗抑郁药(非抑郁非用药组)。对12至18岁青少年的抑郁症状(患者健康问卷-2得分≥3)及自杀倾向进行了评估。采用混合效应逻辑回归分析关联,并对混杂因素进行了校正。
与无孕期抑郁(非抑郁非用药组)相比,母亲孕期抑郁与青少年抑郁症状(用药组优势比[OR]:1.50,95%置信区间[CI]:1.23 - 1.84;未用药组OR:1.59,CI:1.34 - 1.88)及自杀倾向(用药组OR:2.36,CI:1.67 - 3.34;未用药组OR:1.54,CI:1.10 - 2.14)的较高几率相关。与未接触抗抑郁药的青少年(未用药组)相比,孕期接触抑郁及抗抑郁药的青少年出现抑郁症状的几率并未更高(用药组OR:0.95,CI:0.74 - 1.21)。然而,他们出现自杀倾向的几率虽无统计学意义但更高(用药组OR:1.54,CI:0.99 - 2.39)。
我们的研究结果表明,母亲孕期抑郁与青少年抑郁症状及自杀倾向相关,且子宫内接触抗抑郁药并不会特别增加抑郁症状的风险。虽然无统计学意义,但接触抗抑郁药的青少年自杀倾向几率增加表明可能存在关联;然而,仍需进一步研究。经重复验证后,本研究结果可能为考虑使用抗抑郁药治疗母亲孕期抑郁的相关选项时的共同临床决策提供参考。